143 related articles for article (PubMed ID: 16209231)
21. Gastric acid secretion, oesophageal acid reflux, and oesophagitis in patients with symptomatic gastro-oesophageal reflux.
Matikainen M
Scand J Gastroenterol; 1981; 16(8):1043-8. PubMed ID: 7336131
[TBL] [Abstract][Full Text] [Related]
22. [The course of gastroesophageal reflux disease in elderly patients with concomitant ischemic heart disease].
Zvenigorodskaia LA; Taranchenko IuV
Ter Arkh; 2006; 78(2):42-5. PubMed ID: 16613096
[TBL] [Abstract][Full Text] [Related]
23. Ambulatory oesophageal pH-metry. Position paper of the Working Team on Oesophageal pH-metry by the GISMAD (Gruppo Italiano di Studio sulla Motilità dell'Apparato Digerente).
Pace F; Annese V; Ceccatelli P; Fei L
Dig Liver Dis; 2000 May; 32(4):357-64. PubMed ID: 11515635
[TBL] [Abstract][Full Text] [Related]
24. Symptomatic gastro-oesophageal reflux, abnormal oesophageal acid exposure, and mucosal acid sensitivity are three separate, though related, aspects of gastro-oesophageal reflux disease.
Howard PJ; Maher L; Pryde A; Heading RC
Gut; 1991 Feb; 32(2):128-32. PubMed ID: 1864528
[TBL] [Abstract][Full Text] [Related]
25. Assessment of clinical severity and investigation of uncomplicated gastroesophageal reflux disease and noncardiac angina-like chest pain.
Lemire S
Can J Gastroenterol; 1997 Sep; 11 Suppl B():37B-40B. PubMed ID: 9347176
[TBL] [Abstract][Full Text] [Related]
26. Role of manometry and pH-metry in patients with symptoms and signs of gastroesophageal reflux disease.
Bresadola V; Dado G; Terrosu G; Alessandrini V; Marcellino MG; Bresadola F
Chir Ital; 2003; 55(6):785-90. PubMed ID: 14725217
[TBL] [Abstract][Full Text] [Related]
27. Disease progression in gastro-oesophageal reflux disease as determined by repeat oesophageal pH monitoring and endoscopy 3 to 4.5 years after diagnosis.
McDougall NI; Johnston BT; Collins JS; McFarland RJ; Love AH
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1161-7. PubMed ID: 9471021
[TBL] [Abstract][Full Text] [Related]
28. Combined pH-metry/impedance monitoring increases the diagnostic yield in patients with atypical gastroesophageal reflux symptoms.
Bajbouj M; Becker V; Neuber M; Schmid RM; Meining A
Digestion; 2007; 76(3-4):223-8. PubMed ID: 18174685
[TBL] [Abstract][Full Text] [Related]
29. Gastroesophageal reflux in patients with laryngeal disorders.
Vanhemmens S; Wellens W; Tack J
B-ENT; 2005; 1(3):117-23. PubMed ID: 16255496
[TBL] [Abstract][Full Text] [Related]
30. Roles of gastric acid and pH in the pathogenesis of gastro-oesophageal reflux disease.
Dent J
Scand J Gastroenterol Suppl; 1994; 201():55-61. PubMed ID: 8047825
[TBL] [Abstract][Full Text] [Related]
31. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.
Pace F; Bollani S; Molteni P; Bianchi Porro G
Dig Liver Dis; 2004 Feb; 36(2):111-5. PubMed ID: 15002817
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic utility of the oesophageal balloon distension test in the evaluation of oesophageal chest pain.
Nasr I; Attaluri A; Coss-Adame E; Rao SS
Aliment Pharmacol Ther; 2012 Jun; 35(12):1474-81. PubMed ID: 22524415
[TBL] [Abstract][Full Text] [Related]
33. [Postoperative evaluation of esophageal mucosal change dynamics in patients with reflux diseases].
Wallner G; Misiuna P; Chibowski D; Polkowski W; Abramowicz K; Sory A
Wiad Lek; 1997; 50 Suppl 1 Pt 1():273-81. PubMed ID: 9446369
[TBL] [Abstract][Full Text] [Related]
34. Oesophageal sensitivity to acid in patients with non-cardiac chest pain: is the oesophagus hypersensitive?
Galmiche JP; Scarpignato C
Eur J Gastroenterol Hepatol; 1995 Dec; 7(12):1152-9. PubMed ID: 8789304
[TBL] [Abstract][Full Text] [Related]
35. [24-hour simultaneous esophagogastric pH-metry in children].
Angulo JM; Gorostiaga L; Tovar JA
Cir Pediatr; 1992 Jul; 5(3):160-5. PubMed ID: 1389973
[TBL] [Abstract][Full Text] [Related]
36. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
Bautista J; Fullerton H; Briseno M; Cui H; Fass R
Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
[TBL] [Abstract][Full Text] [Related]
37. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
38. Review article: intragastric and oesophageal pH monitoring in patients with gastro-oesophageal reflux disease.
Katz PO
Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():3-11. PubMed ID: 16483265
[TBL] [Abstract][Full Text] [Related]
39. Relationship between acceleration of gastric emptying and oesophageal acid exposure in patients with endoscopy-negative gastro-oesophageal reflux disease.
Carmagnola S; Fraquelli M; Cantù P; Conte D; Penagini R
Scand J Gastroenterol; 2006 Jul; 41(7):767-72. PubMed ID: 16785188
[TBL] [Abstract][Full Text] [Related]
40. Review article: the role of pH monitoring in extraoesophageal gastro-oesophageal reflux disease.
Vaezi MF
Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():40-9. PubMed ID: 16483269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
